Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis
about
Chronic Hepatitis C Infection in Children: Current Treatment and New TherapiesWhat's new in hepatitis C virus infections in children?Treating hepatitis C virus in children: time for a new paradigmOverview and recent trends of systematic reviews and meta-analyses in hepatology.The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis.Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.HCV treatment in children and young adults with HIV/HCV co-infection in Europe.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentIL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis C.Paediatric Virology: A rapidly increasing educational challenge.Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian childrenNew treatments for chronic hepatitis C: an overview for paediatricians.Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C.New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs).Hepatitis B and C.Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.Pegylated interferon for hepatitis C virus infection in Down syndrome.Hepatitis C virus infection in children and adolescents.Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
P2860
Q26781770-023D4B77-01FC-4976-A029-5E228A512524Q26782000-F98A08B9-24FA-41E4-8F15-F7CAF6CD658BQ26851883-767A39E5-95DB-4831-BF20-100424C04907Q30434752-2A1AEEEE-3D40-4FCB-8142-BB0555648B11Q33621649-5C814DAC-F09E-47A6-84E1-259BA1DB9C1EQ36182539-C3ECFE81-FE57-4116-AA2B-A9E823F177C3Q36301391-A34AFD73-412A-4CC2-9091-1106C90F9D91Q36310310-1FE6E569-9142-4B56-8495-CF0BCBB2CAF8Q36855565-54BBCAF7-FCEB-453F-82AA-E832C086569AQ37098372-D68ED6CE-71A2-4B91-9A1A-1AC18769156DQ37100669-34BA6F0A-EFEA-427D-8B59-12C499B13918Q37428173-A063F856-692C-4DBE-8DAE-E3041A21FCCCQ37697706-43C10934-ACF7-4BD9-B37E-6A6F24F3F589Q37724686-4659FB83-E0A8-443C-9494-12150685A574Q38282842-F7D7257D-CCC1-4650-8847-3E7E2596A80DQ38450468-17F6F82D-C538-4567-BB98-14BDE2CF46E5Q39016874-F906785E-7CED-4873-BD2F-AF886E4A6130Q39305112-897DD085-6314-4E98-B2FC-E207AD2C98D6Q41535163-06814B49-A564-4D4E-A1F3-2571C3841306Q43987188-981506F7-EC3D-4519-8836-0D1C070B39A3Q47108259-CD06A7E7-081D-4FD6-A656-83089560F136Q51181794-BB0654CA-8A46-48CB-A804-DDBE83AF5FB2Q54277218-C701F9C0-14A1-495D-9216-28B114DFF0BFQ58582162-B511837D-A360-43E6-BA8F-3F3976A1E577
P2860
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy and safety of pegylat ...... matic review and meta-analysis
@ast
Efficacy and safety of pegylat ...... matic review and meta-analysis
@en
Efficacy and safety of pegylat ...... matic review and meta-analysis
@nl
type
label
Efficacy and safety of pegylat ...... matic review and meta-analysis
@ast
Efficacy and safety of pegylat ...... matic review and meta-analysis
@en
Efficacy and safety of pegylat ...... matic review and meta-analysis
@nl
prefLabel
Efficacy and safety of pegylat ...... matic review and meta-analysis
@ast
Efficacy and safety of pegylat ...... matic review and meta-analysis
@en
Efficacy and safety of pegylat ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P50
P3181
P356
P1476
Efficacy and safety of pegylat ...... matic review and meta-analysis
@en
P2093
Curtis L Cooper
Edward J Mills
Eric Druyts
Steve Kanters
P2860
P3181
P356
10.1093/CID/CIS1031
P407
P577
2013-04-01T00:00:00Z